Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gatoulis Sc"'
Publikováno v:
Inflammopharmacology
A recently developed fast-release aspirin tablet formulation has been evaluated in two different pain models. The dental impaction pain model and the sore throat pain model are widely used for assessing analgesia, including acute mild-to-moderate pai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a859be774a9c98f568069ab2e004721
Autor:
La Cerda J; Urology San Antonio, San Antonio, TX, USA., Thorley J; Intermountain Healthcare, Murray, UT, USA., Sieber P; Urological Associates of Lancaster, Lancaster, PA, USA., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Flanders SC; Sumitomo Pharma America Inc., Cambridge, MA, USA., Gatoulis SC; Pfizer Inc., New York, NY, USA., Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Nov 06, pp. 1-12. Date of Electronic Publication: 2024 Nov 06.
Autor:
Spratt DE; Radiation Oncology, UH Seidman Cancer Center/Case Western Reserve University, Cleveland, OH 441062, USA., Dorff T; Medical Oncology, City of Hope, Duarte, CA 910103, USA., McKay RR; Medical Oncology, UC San Diego, La Jolla, CA 920374, USA., Lowentritt BH; Urology, Chesapeake Urology, Towson, MD 212045, USA., Fallick M; Myovant Sciences Inc., Brisbane, CA 940056, USA., Gatoulis SC; Pfizer, New York, NY 100177, USA., Flanders SC; Myovant Sciences Inc., Brisbane, CA & Sumitomo Pharma America Inc., Marlborough, MA 017528, USA., Ross AE; Urology, Northwestern Medicine, Chicago, IL 60611, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Apr; Vol. 20 (12), pp. 727-738. Date of Electronic Publication: 2024 Mar 15.
Autor:
Preston MA; Brigham and Women's Hospital, Boston, MA, USA., Hong A; Pfizer Inc., New York, NY, USA., Dufour R; Myovant Sciences, Inc., Brisbane, CA, USA., Marden JR; Analysis Group, Inc., Boston, MA, USA., Kirson NY; Analysis Group, Inc., Boston, MA, USA., Gatoulis SC; Pfizer Inc., New York, NY, USA., Kongara S; Analysis Group, Inc., Boston, MA, USA., Gandhi R; Myovant Sciences, Inc., Brisbane, CA, USA., Morgans AK; Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2024 Jan 11; Vol. 60, pp. 32-35. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2024).
Autor:
De La Cerda J; Urology San Antonio, 3327 Research Plaza Suite 403, San Antonio, TX, 78235, USA. Jose.DeLaCerda@urologysa.com., Dunshee C; Arizona Urology Specialists, Tucson, AZ, USA., Gervasi L; SouthWest Urology LLC, Middleburg Heights, OH, USA., Sieber P; Urological Associates of Lancaster, Lancaster, PA, USA., Belkoff L; Division of Urology, MidLantic Urology/Main Line Health, Bala Cynwyd, PA, USA., Tutrone R; Chesapeake Urology, Towson, MD, USA., Lu S; Myovant Sciences, Inc., Brisbane, CA, USA., Gatoulis SC; Pfizer Inc., New York, NY, USA., Brown B; Myovant Sciences, Inc., Brisbane, CA, USA., Migoya E; Myovant Sciences, Inc., Brisbane, CA, USA., Shore N; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
Publikováno v:
Targeted oncology [Target Oncol] 2023 May; Vol. 18 (3), pp. 383-390. Date of Electronic Publication: 2023 Apr 15.
Autor:
Miner PB; Oklahoma Foundation for Digestive Research, Oklahoma City, OK, USA. philip-miner@ofdr.com., Johnson DA; Eastern Virginia Medical School, Norfolk, VA, USA., Katz PO; Weill Cornell Medicine, New York, NY, USA., Li J; Biostatistics, Pfizer Consumer Healthcare, Madison, NJ, USA., Gatoulis SC; Global Clinical Research, Pfizer Consumer Healthcare, Madison, NJ, USA., Pollack C; Global R&D, Pfizer Consumer Healthcare, Madison, NJ, USA.
Publikováno v:
Advances in therapy [Adv Ther] 2018 Nov; Vol. 35 (11), pp. 2024-2040. Date of Electronic Publication: 2018 Sep 25.
Publikováno v:
Minerva medica [Minerva Med] 2016 Jun; Vol. 107 (3), pp. 125-30. Date of Electronic Publication: 2016 Apr 01.
Autor:
Voelker M; Bayer HealthCare, Leverkusen, Germany. michael.voelker@bayer.com., Schachtel BP; Schachtel Research Company, Jupiter, FL, USA., Cooper SA; Clinical Trial Consultant, Palm Beach Gardens, FL, USA., Gatoulis SC; Bayer HealthCare, Whippany, NJ, USA.
Publikováno v:
Inflammopharmacology [Inflammopharmacology] 2016 Feb; Vol. 24 (1), pp. 43-51. Date of Electronic Publication: 2015 Nov 24.
Autor:
Kanani K; School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA. kananikunal@gmail.com., Gatoulis SC; Bayer HealthCare, 100 Bayer Blvd, Whippany, NJ 07981, USA. sergio.gatoulis@bayer.com., Voelker M; Bayer HealthCare, Building K56, 51368 Leverkusen, Germany. michael.voelker@bayer.com.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2015 Aug 03; Vol. 7 (3), pp. 188-98. Date of Electronic Publication: 2015 Aug 03.
Autor:
Gatoulis SC; Bayer HealthCare, Morristown, New Jersey; Rutgers, The State University of New Jersey, Piscataway, NJ, USA., Voelker M, Fisher M
Publikováno v:
Clinical therapeutics [Clin Ther] 2012 Jan; Vol. 34 (1), pp. 138-48. Date of Electronic Publication: 2011 Dec 14.